Patients manifesting both amyotrophic lateral sclerosis and frontotemporal dementia and not carrying the C9orf72 expansion mutation harbour a substantial genetic burden.
Read moreGenetic burden in frontotemporal dementia and amyotrophic lateral sclerosis
Dr. María Carmona-Iragui has defended today her Doctoral Thesis entitled: “Sporadic cerebral amyloid angiopathy: beyond lobar intracerebral hemorrhage. Multimodal biomarker studies of atypical presentations”.
How can I collaborate? 1. Volunteer as a research participant in the SPIN cohort In the SPIN cohort (Sant Pau Initiative on Neurodegeneration), healthy volunteers receive a neuropsychological evaluation, analytical and neuroimaging tests for comparative purpose. More information about the SPIN cohort can be found here. To be eligible as a volunteer in the SPIN … Read more
In the Sant Pau Memory Unit, we have a team that is specifically dedicated to the development of advanced therapies that are offered through clinical trials. This team consists of neurologists, neuropsychologists and a research nurse. Their aim is to offer new drugs under development to all patients that could potentially benefit from them. Most … Read more
The multidisciplinary nature of the Sant Pau Memory Unit has favored the development of translational research lines that aim to bridge the gap between bench and clinic. Consequently, many of the results from these research lines have an immediate impact on clinical practice. Biomarkers This research line is focused on the identification and characterization of … Read more
Our Molecular Genetics Unit is focused on understanding the genetic causes underlying neurodegenerative disorders, and developing new genetic-based biomarkers to aid in disease diagnosis and prognosis. To accomplish this, we use state-of-the-art genetic tools such as next-generation sequencing, ddPCR, etc. applied to patients that have been diagnosed and followed-up by our memory clinic team. We … Read more